| Bioactivity | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine |
| CAS | 161615-21-0 |
| Formula | C24H21N3O9 |
| Molar Mass | 495.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine
CAS: 161615-21-0 F: C24H21N3O9 W: 495.44
2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broa
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.